Data from the ECLIPSE investigators, who studied a larger cohort of COPD patients, showed that several biomarkers correlated with baseline FEV1 but only one correlated with rate of decline in FEV1, the Clara-Cell Protein 16 (CC-16)10. This evidence concerns the gene SCGB1A1 and chronic obstructive pulmonary disease.